Filtering by:
LymphomaLymphoma Survivor Shares Positive Outlook
“It was such a silly little thing, to dress up as a child might, and treat the whole thing like a big circus, but it provided a way to help both myself and others stay positive,” said Jones.
Non-Hodgkin Lymphoma Survivor Copes With Coronavirus Pandemic
Phyllis Alsterberg was recently treated for non-Hodgkin lymphoma. She hasn’t left her home in New York City much since the coronavirus outbreak started because she has a weakened immune system and she’s worried about getting sick.
Young Adult Persists, Gets Help for Hodgkin Lymphoma
When Katie Dimmock, 26, learned she had cancer, she was actually a little relieved. “It was one of the worst – but at the same time best – moments,” said Dimmock.
Breast Implant Recall: What You Need to Know
The pharmaceutical company Allergan has recalled all BioCell textured breast implants at the request of the US Food and Drug Administration (FDA) because they have been linked to a rare type of lymphoma.
Lymphoma Survivor Becomes Nurse to Help Cancer Patients
When Crystal Zunino was diagnosed with non-Hodgkin lymphoma in January 2015, she was just half-way through her first year as a new middle-school math teacher in Warner Robins, Georgia.
FDA Approves Polivy (Polatuzumab Vedotin-piiq) for Lymphoma
The US Food and Drug Administration (FDA) has approved the antibody-drug conjugate Polivy (polatuzumab vedotin-piiq) to treat people with diffuse large B-cell lymphoma (DLBCL).
FDA Approves First Biosimilar for Non-Hodgkin Lymphoma
The US Food and Drug Administration (FDA) has approved Truxima (rituximab-abbs), the first biosimilar drug to treat adults with some types of non-Hodgkin lymphoma.
A Pioneer in Developing Drugs for People with T-Cell Lymphoma
Owen A. O'Connor, MD, PhD, was awarded the prestigious American Cancer Society Clinical Research Professor grant in July 2018. He was selected because of his expertise and ongoing work to develop drugs to improve treatments for people with Hodgkin and non-Hodgkin lymphomas. He's a professor and researcher at the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center in New York, New York.
